{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T02:47:39Z","timestamp":1788058059318,"version":"build-2784847793"},"reference-count":278,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2023,5,5]],"date-time":"2023-05-05T00:00:00Z","timestamp":1683244800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Institute on Drug Abuse","award":["R01DA050540"],"award-info":[{"award-number":["R01DA050540"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is the causative pathogen of the coronavirus disease 2019 (COVID-19) pandemic, a fatal respiratory illness. The associated risk factors for COVID-19 are old age and medical comorbidities. In the current combined antiretroviral therapy (cART) era, a significant portion of people living with HIV-1 (PLWH) with controlled viremia is older and with comorbidities, making these people vulnerable to SARS-CoV-2 infection and COVID-19-associated severe outcomes. Additionally, SARS-CoV-2 is neurotropic and causes neurological complications, resulting in a health burden and an adverse impact on PLWH and exacerbating HIV-1-associated neurocognitive disorder (HAND). The impact of SARS-CoV-2 infection and COVID-19 severity on neuroinflammation, the development of HAND and preexisting HAND is poorly explored. In the present review, we compiled the current knowledge of differences and similarities between SARS-CoV-2 and HIV-1, the conditions of the SARS-CoV-2\/COVID-19 and HIV-1\/AIDS syndemic and their impact on the central nervous system (CNS). Risk factors of COVID-19 on PLWH and neurological manifestations, inflammatory mechanisms leading to the neurological syndrome, the development of HAND, and its influence on preexisting HAND are also discussed. Finally, we have reviewed the challenges of the present syndemic on the world population, with a particular emphasis on PLWH.<\/jats:p>","DOI":"10.3390\/v15051117","type":"journal-article","created":{"date-parts":[[2023,5,5]],"date-time":"2023-05-05T08:12:11Z","timestamp":1683274331000},"page":"1117","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["The Impact of COVID-19 on People Living with HIV-1 and HIV-1-Associated Neurological Complications"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6038-2416","authenticated-orcid":false,"given":"Debashis","family":"Dutta","sequence":"first","affiliation":[{"name":"Department of Pharmacology and Experimental Neuroscience, College of Medicine, University of Nebraska Medical Center, Omaha, NE 68198-5880, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianuo","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Experimental Neuroscience, College of Medicine, University of Nebraska Medical Center, Omaha, NE 68198-5880, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3450-8876","authenticated-orcid":false,"given":"Huangui","family":"Xiong","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Experimental Neuroscience, College of Medicine, University of Nebraska Medical Center, Omaha, NE 68198-5880, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,5,5]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.mpdhp.2020.12.001","article-title":"Pandemics and pathology: A reflection on influenza, HIV\/AIDS and SARS (COVID-19) pandemic infections","volume":"27","author":"Lucas","year":"2021","journal-title":"Diagn. Histopathol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1002\/hpm.3133","article-title":"COVID-19: Learning from the HIV\/AIDS pandemic response in Africa","volume":"36","author":"Olufadewa","year":"2021","journal-title":"Int. J. Health Plan. Manag."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.7150\/ijms.73134","article-title":"SARS-CoV-2 and HIV-1: So Different yet so Alike. Immune Response at the Cellular and Molecular Level","volume":"19","author":"Demoliou","year":"2022","journal-title":"Int. J. Med. Sci."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1056\/NEJMoa2001017","article-title":"A Novel Coronavirus from Patients with Pneumonia in China, 2019","volume":"382","author":"Zhu","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1056\/NEJMoa2001316","article-title":"Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia","volume":"382","author":"Li","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Coronaviridae Study Group of the International Committee on Taxonomy of Viruses (2020). The species Severe acute respiratory syndrome-related coronavirus: Classifying 2019-nCoV and naming it SARS-CoV-2. Nat. Microbiol., 5, 536\u2013544.","DOI":"10.1038\/s41564-020-0695-z"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1126\/science.8493571","article-title":"How does HIV cause AIDS?","volume":"260","author":"Weiss","year":"1993","journal-title":"Science"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"92","DOI":"10.7326\/0003-4819-100-1-92","article-title":"NIH conference. Acquired immunodeficiency syndrome: Epidemiologic, clinical, immunologic, and therapeutic considerations","volume":"100","author":"Fauci","year":"1984","journal-title":"Ann. Intern. Med."},{"key":"ref_9","unstructured":"WHO (2022, December 08). WHO Coronavirus (COVID-19) Dashboard. Available online: https:\/\/covid19.who.int\/."},{"key":"ref_10","unstructured":"UNAIDS (2022, December 08). AIDS BY THE NUMBERS. Available online: https:\/\/www.unaids.org\/en."},{"key":"ref_11","unstructured":"World Health Organization (2022, December 09). HIV Data and Statistics. Available online: https:\/\/www.who.int\/teams\/global-hiv-hepatitis-and-stis-programmes\/hiv\/strategic-information\/hiv-data-and-statistics."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1007\/s10461-020-02871-9","article-title":"The Burden of COVID-19 in People Living with HIV: A Syndemic Perspective","volume":"24","author":"Shiau","year":"2020","journal-title":"AIDS Behav."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s12981-021-00335-1","article-title":"COVID-19 and HIV infection co-pandemics and their impact: A review of the literature","volume":"18","author":"Gatechompol","year":"2021","journal-title":"AIDS Res. Ther."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.puhe.2022.05.017","article-title":"SARS-CoV-2 seroprevalence among people living with HIV in Guinea-Bissau","volume":"209","author":"Dutschke","year":"2022","journal-title":"Public Health"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1097\/QAI.0000000000002414","article-title":"Intersecting Pandemics: Impact of SARS-CoV-2 (COVID-19) Protective Behaviors on People Living with HIV, Atlanta, Georgia","volume":"85","author":"Kalichman","year":"2020","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1080\/25787489.2020.1844521","article-title":"COVID-19 symptoms and SARS-CoV-2 infection among people living with HIV in the US: The MACS\/WIHS combined cohort study","volume":"21","author":"Springer","year":"2020","journal-title":"HIV Res. Clin. Pract."},{"key":"ref_17","unstructured":"UNAIDS (2022, December 07). People Living with HIV at Higher Risk of COVID-19 Illness but Have Lower Access to COVID-19 Vaccines. Available online: https:\/\/www.unaids.org\/en\/site-search#?cludoquery=COVID-19%20HIV%20double%20jeopardy%20&cludopage=1&cludorefurl=https%3A%2F%2Fwww.unaids.org%2Fen&cludorefpt=UNAIDS&cludoinputtype=standard."},{"key":"ref_18","unstructured":"World Health Organization (2022, December 28). Coronavirus Disease (COVID-19) and People Living with HIV. Available online: https:\/\/www.who.int\/news-room\/questions-and-answers\/item\/coronavirus-disease-(COVID-19)-COVID-19-and-people-living-with-hiv."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1093\/cid\/ciaa579","article-title":"Clinical Features and Outcomes of Patients with Human Immunodeficiency Virus with COVID-19","volume":"71","author":"Gervasoni","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"e24","DOI":"10.1016\/S2352-3018(20)30305-2","article-title":"HIV infection and COVID-19 death: A population-based cohort analysis of UK primary care data and linked national death registrations within the OpenSAFELY platform","volume":"8","author":"Bhaskaran","year":"2021","journal-title":"Lancet HIV"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1093\/cid\/ciaa635","article-title":"Clinical Characteristics and Outcomes in People Living with Human Immunodeficiency Virus Hospitalized for Coronavirus Disease 2019","volume":"71","author":"Shalev","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"F3","DOI":"10.1097\/QAD.0000000000002666","article-title":"Characteristics and outcomes of COVID-19 in patients with HIV: A multicentre research network study","volume":"34","author":"Hadi","year":"2020","journal-title":"AIDS"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1093\/infdis\/jiaa380","article-title":"Clinical Outcomes and Immunologic Characteristics of Coronavirus Disease 2019 in People with Human Immunodeficiency Virus","volume":"223","author":"Ho","year":"2021","journal-title":"J. Infect. Dis."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"e932962","DOI":"10.12659\/MSM.932962","article-title":"A Review of Neurological Involvement in Patients with SARS-CoV-2 Infection","volume":"27","author":"Xu","year":"2021","journal-title":"Med. Sci. Monit."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Guadarrama-Ortiz, P., Choreno-Parra, J.A., Sanchez-Martinez, C.M., Pacheco-Sanchez, F.J., Rodriguez-Nava, A.I., and Garcia-Quintero, G. (2020). Neurological Aspects of SARS-CoV-2 Infection: Mechanisms and Manifestations. Front. Neurol., 11.","DOI":"10.3389\/fneur.2020.01039"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1126\/science.abm2052","article-title":"Nervous system consequences of COVID-19","volume":"375","author":"Spudich","year":"2022","journal-title":"Science"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/02648725.2022.2108998","article-title":"Putative role of mitochondria in SARS-CoV-2 mediated brain dysfunctions: A prospect","volume":"8","author":"Maurya","year":"2022","journal-title":"Biotechnol. Genet. Eng. Rev."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1186\/s13054-020-03121-z","article-title":"Neurological manifestations of COVID-19: A systematic review","volume":"24","author":"Nepal","year":"2020","journal-title":"Crit. Care"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/ane.13266","article-title":"Neurological Manifestations of COVID-19: A systematic review and current update","volume":"142","author":"Whittaker","year":"2020","journal-title":"Acta Neurol. Scand."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/nri1527","article-title":"The neuropathogenesis of AIDS","volume":"5","year":"2005","journal-title":"Nat. Rev. Immunol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1097\/00005072-199911000-00005","article-title":"Early entry and widespread cellular involvement of HIV-1 DNA in brains of HIV-1 positive asymptomatic individuals","volume":"58","author":"An","year":"1999","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1212\/WNL.42.9.1736","article-title":"Early viral brain invasion in iatrogenic human immunodeficiency virus infection","volume":"42","author":"Davis","year":"1992","journal-title":"Neurology"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"e20202135","DOI":"10.1084\/jem.20202135","article-title":"Neuroinvasion of SARS-CoV-2 in human and mouse brain","volume":"218","author":"Song","year":"2021","journal-title":"J. Exp. Med."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s12035-021-02593-6","article-title":"SARS-CoV-2 Spike Glycoprotein S1 Induces Neuroinflammation in BV-2 Microglia","volume":"59","author":"Olajide","year":"2022","journal-title":"Mol. Neurobiol."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Albornoz, E.A., Amarilla, A.A., Modhiran, N., Parker, S., Li, X.X., Wijesundara, D.K., Aguado, J., Zamora, A.P., McMillan, C.L.D., and Liang, B. (2022). SARS-CoV-2 drives NLRP3 inflammasome activation in human microglia through spike protein. Mol. Psychiatry, 1\u201316.","DOI":"10.1038\/s41380-022-01831-0"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"100019","DOI":"10.1016\/j.jve.2020.100019","article-title":"Impact of COVID-19 on people living with HIV: A review","volume":"6","author":"Prabhu","year":"2020","journal-title":"J. Virus Erad."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1089\/aid.2020.0136","article-title":"Insult to Injury-Potential Contribution of Coronavirus Disease-19 to Neuroinflammation and the Development of HIV-Associated Neurocognitive Disorders","volume":"37","author":"Williams","year":"2021","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.coviro.2014.12.009","article-title":"Viral diseases of the central nervous system","volume":"11","author":"Swanson","year":"2015","journal-title":"Curr. Opin. Virol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.4103\/1673-5374.327323","article-title":"SARS-CoV-2 involvement in central nervous system tissue damage","volume":"17","author":"Haidar","year":"2022","journal-title":"Neural Regen. Res."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"104583","DOI":"10.1016\/j.meegid.2020.104583","article-title":"Emergence and molecular mechanisms of SARS-CoV-2 and HIV to target host cells and potential therapeutics","volume":"85","author":"Saleemi","year":"2020","journal-title":"Infect. Genet. Evol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1080\/22221751.2020.1736644","article-title":"A tug-of-war between severe acute respiratory syndrome coronavirus 2 and host antiviral defence: Lessons from other pathogenic viruses","volume":"9","author":"Fung","year":"2020","journal-title":"Emerg. Microbes Infect."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"846","DOI":"10.7150\/ijms.50133","article-title":"Similarities and differences between HIV and SARS-CoV-2","volume":"18","year":"2021","journal-title":"Int. J. Med. Sci."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1007\/s13365-020-00897-2","article-title":"Studying the neuropsychological sequelae of SARS-CoV-2: Lessons learned from 35 years of neuroHIV research","volume":"26","author":"Levine","year":"2020","journal-title":"J. Neurovirol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/S1473-3099(22)00015-9","article-title":"The origin of SARS-CoV-2 variants of concern","volume":"22","author":"Burki","year":"2022","journal-title":"Lancet Infect. Dis."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"596631","DOI":"10.3389\/fimmu.2020.596631","article-title":"Sharing CD4+ T Cell Loss: When COVID-19 and HIV Collide on Immune System","volume":"11","author":"Peng","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.biochi.2021.11.005","article-title":"SARS-CoV-2 may affect the immune response via direct inhibition of T cell receptor: Mechanistic hypothesis and rationale","volume":"195","author":"Sigalov","year":"2022","journal-title":"Biochimie"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1111\/hiv.12911","article-title":"Coronavirus disease 2019 (COVID-19) outcomes in HIV\/AIDS patients: A systematic review","volume":"21","author":"Cooper","year":"2020","journal-title":"HIV Med."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1128\/CMR.9.1.100","article-title":"Molecular biology and pathogenesis of animal lentivirus infections","volume":"9","author":"Clements","year":"1996","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1056\/NEJM198512123132401","article-title":"Isolation of HTLV-III from cerebrospinal fluid and neural tissues of patients with neurologic syndromes related to the acquired immunodeficiency syndrome","volume":"313","author":"Ho","year":"1985","journal-title":"N. Engl. J. Med."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1212\/WNL.0000000000011735","article-title":"HIV in the Brain: From Devastating Dementia to White Matter Hyperintensities","volume":"96","author":"Saylor","year":"2021","journal-title":"Neurology"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1212\/WNL.38.1.9","article-title":"Early penetration of the blood-brain-barrier by HIV","volume":"38","author":"Resnick","year":"1988","journal-title":"Neurology"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"7089","DOI":"10.1073\/pnas.83.18.7089","article-title":"Cellular localization of human immunodeficiency virus infection within the brains of acquired immune deficiency syndrome patients","volume":"83","author":"Wiley","year":"1986","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1080\/13550280902973952","article-title":"Human immunodeficiency virus type 1 in the central nervous system leads to decreased dopamine in different regions of postmortem human brains","volume":"15","author":"Kumar","year":"2009","journal-title":"J. Neurovirol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1189\/jlb.0503205","article-title":"Mononuclear phagocyte immunity and the neuropathogenesis of HIV-1 infection","volume":"74","author":"Persidsky","year":"2003","journal-title":"J. Leukoc. Biol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"3499","DOI":"10.4049\/jimmunol.158.7.3499","article-title":"A model for monocyte migration through the blood-brain barrier during HIV-1 encephalitis","volume":"158","author":"Persidsky","year":"1997","journal-title":"J. Immunol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.4049\/jimmunol.156.3.1284","article-title":"Mechanisms for the transendothelial migration of HIV-1-infected monocytes into brain","volume":"156","author":"Nottet","year":"1996","journal-title":"J. Immunol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1080\/13550280390194073","article-title":"Pathogenesis of human immunodeficiency virus-induced neurological disease","volume":"9","author":"Albright","year":"2003","journal-title":"J. Neurovirol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/s00281-022-00953-5","article-title":"Neuropathogenesis of HIV-1: Insights from across the spectrum of acute through long-term treated infection","volume":"44","author":"Killingsworth","year":"2022","journal-title":"Semin. Immunopathol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/S1473-3099(13)70269-X","article-title":"HIV-associated neurocognitive disorder","volume":"13","author":"Clifford","year":"2013","journal-title":"Lancet Infect. Dis."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1212\/01.WNL.0000287431.88658.8b","article-title":"Updated research nosology for HIV-associated neurocognitive disorders","volume":"69","author":"Antinori","year":"2007","journal-title":"Neurology"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"362","DOI":"10.3389\/fcimb.2019.00362","article-title":"Microglial Cells: The Main HIV-1 Reservoir in the Brain","volume":"9","author":"Wallet","year":"2019","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Borrajo Lopez, A., Penedo, M.A., Rivera-Baltanas, T., Perez-Rodriguez, D., Alonso-Crespo, D., Fernandez-Pereira, C., Olivares, J.M., and Agis-Balboa, R.C. (2021). Microglia: The Real Foe in HIV-1-Associated Neurocognitive Disorders?. Biomedicines, 9.","DOI":"10.3390\/biomedicines9080925"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"167","DOI":"10.2174\/187152611795589663","article-title":"HIV treatment adherence, drug resistance, virologic failure: Evolving concepts","volume":"11","author":"Nachega","year":"2011","journal-title":"Infect. Disord. Drug. Targets"},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"De Francesco, D., Underwood, J., Post, F.A., Vera, J.H., Williams, I., Boffito, M., Sachikonye, M., Anderson, J., Mallon, P.W., and Winston, A. (2016). Defining cognitive impairment in people-living-with-HIV: The POPPY study. BMC Infect. Dis., 16.","DOI":"10.1186\/s12879-016-1970-8"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/nrneurol.2016.53","article-title":"HIV-associated neurocognitive disorder\u2014Pathogenesis and prospects for treatment","volume":"12","author":"Saylor","year":"2016","journal-title":"Nat. Rev. Neurol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1007\/s00415-017-8503-2","article-title":"HIV-1-associated neurocognitive disorder: Epidemiology, pathogenesis, diagnosis, and treatment","volume":"264","author":"Eggers","year":"2017","journal-title":"J. Neurol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1089\/aid.2020.0161","article-title":"What HIV in the Brain Can Teach Us About SARS-CoV-2 Neurological Complications?","volume":"37","author":"Campbell","year":"2021","journal-title":"AIDS Res. Hum. Retrovir."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s11481-020-09944-5","article-title":"The Natural History, Pathobiology, and Clinical Manifestations of SARS-CoV-2 Infections","volume":"15","author":"Machhi","year":"2020","journal-title":"J. Neuroimmune Pharmacol."},{"key":"ref_69","first-page":"361","article-title":"SARS-CoV-2 and Human Immunodeficiency Virus: Pathogen Pincer Attack","volume":"13","author":"Evans","year":"2021","journal-title":"HIV AIDS"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","article-title":"A pneumonia outbreak associated with a new coronavirus of probable bat origin","volume":"579","author":"Zhou","year":"2020","journal-title":"Nature"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1001\/jama.2020.1585","article-title":"Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China","volume":"323","author":"Wang","year":"2020","journal-title":"JAMA"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1002\/acn3.51210","article-title":"Frequent neurologic manifestations and encephalopathy-associated morbidity in COVID-19 patients","volume":"7","author":"Liotta","year":"2020","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1056\/NEJMc2011400","article-title":"Multiorgan and Renal Tropism of SARS-CoV-2","volume":"383","author":"Puelles","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1056\/NEJMc2019373","article-title":"Neuropathological Features of COVID-19","volume":"383","author":"Solomon","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ijid.2020.03.062","article-title":"A first case of meningitis\/encephalitis associated with SARS-Coronavirus-2","volume":"94","author":"Moriguchi","year":"2020","journal-title":"Int. J. Infect. Dis."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S1474-4422(20)30308-2","article-title":"Neuropathology of patients with COVID-19 in Germany: A post-mortem case series","volume":"19","author":"Matschke","year":"2020","journal-title":"Lancet Neurol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1038\/s41467-022-29440-z","article-title":"Neuropathology and virus in brain of SARS-CoV-2 infected non-human primates","volume":"13","author":"Rutkai","year":"2022","journal-title":"Nat. Commun."},{"key":"ref_78","first-page":"665","article-title":"Infectability of human BrainSphere neurons suggests neurotropism of SARS-CoV-2","volume":"37","author":"Bullen","year":"2020","journal-title":"ALTEX"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.stem.2020.09.016","article-title":"Human Pluripotent Stem Cell-Derived Neural Cells and Brain Organoids Reveal SARS-CoV-2 Neurotropism Predominates in Choroid Plexus Epithelium","volume":"27","author":"Jacob","year":"2020","journal-title":"Cell. Stem Cell."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"eaaz5626","DOI":"10.1126\/science.aaz5626","article-title":"Human CNS barrier-forming organoids with cerebrospinal fluid production","volume":"369","author":"Pellegrini","year":"2020","journal-title":"Science"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1001\/jamaneurol.2020.1127","article-title":"Neurologic Manifestations of Hospitalized Patients with Coronavirus Disease 2019 in Wuhan, China","volume":"77","author":"Mao","year":"2020","journal-title":"JAMA Neurol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"e59136","DOI":"10.7554\/eLife.59136","article-title":"Neuropathogenesis of SARS-CoV-2 infection","volume":"9","author":"Khan","year":"2020","journal-title":"Elife"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/B978-0-12-802395-2.00017-1","article-title":"Acute and chronic viral infections","volume":"145","author":"Deigendesch","year":"2017","journal-title":"Handb. Clin. Neurol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/s41582-020-00453-w","article-title":"Neurological infection with SARS-CoV-2\u2014The story so far","volume":"17","author":"Solomon","year":"2021","journal-title":"Nat. Rev. Neurol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"eabc5801","DOI":"10.1126\/sciadv.abc5801","article-title":"Non-neuronal expression of SARS-CoV-2 entry genes in the olfactory system suggests mechanisms underlying COVID-19-associated anosmia","volume":"6","author":"Brann","year":"2020","journal-title":"Sci. Adv."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/s41593-020-00758-5","article-title":"Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19","volume":"24","author":"Meinhardt","year":"2021","journal-title":"Nat. Neurosci."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"5135","DOI":"10.1021\/acsnano.0c02823","article-title":"Rapid Detection of COVID-19 Causative Virus (SARS-CoV-2) in Human Nasopharyngeal Swab Specimens Using Field-Effect Transistor-Based Biosensor","volume":"14","author":"Seo","year":"2020","journal-title":"ACS Nano"},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Dutta, D., Naiyer, S., Mansuri, S., Soni, N., Singh, V., Bhat, K.H., Singh, N., Arora, G., and Mansuri, M.S. (2022). COVID-19 Diagnosis: A Comprehensive Review of the RT-qPCR Method for Detection of SARS-CoV-2. Diagnostics, 12.","DOI":"10.3390\/diagnostics12061503"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"R373","DOI":"10.1152\/ajpregu.00292.2006","article-title":"Differential expression of neuronal ACE2 in transgenic mice with overexpression of the brain renin-angiotensin system","volume":"292","author":"Doobay","year":"2007","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"7264","DOI":"10.1128\/JVI.00737-08","article-title":"Severe acute respiratory syndrome coronavirus infection causes neuronal death in the absence of encephalitis in mice transgenic for human ACE2","volume":"82","author":"Netland","year":"2008","journal-title":"J. Virol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"e105114","DOI":"10.15252\/embj.2020105114","article-title":"SARS-CoV-2 receptor ACE2 and TMPRSS2 are primarily expressed in bronchial transient secretory cells","volume":"39","author":"Lukassen","year":"2020","journal-title":"EMBO J."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1021\/acschemneuro.0c00172","article-title":"SARS-CoV-2: Olfaction, Brain Infection, and the Urgent Need for Clinical Samples Allowing Earlier Virus Detection","volume":"11","author":"Butowt","year":"2020","journal-title":"ACS Chem. Neurosci."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","article-title":"Clinical Characteristics of Coronavirus Disease 2019 in China","volume":"382","author":"Guan","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1126\/science.abd2985","article-title":"Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity","volume":"370","author":"Ojha","year":"2020","journal-title":"Science"},{"key":"ref_96","doi-asserted-by":"crossref","unstructured":"Kumari, P., Rothan, H.A., Natekar, J.P., Stone, S., Pathak, H., Strate, P.G., Arora, K., Brinton, M.A., and Kumar, M. (2021). Neuroinvasion and Encephalitis Following Intranasal Inoculation of SARS-CoV-2 in K18-hACE2 Mice. Viruses, 13.","DOI":"10.1101\/2020.12.14.422714"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/s41392-021-00591-7","article-title":"The olfactory route is a potential way for SARS-CoV-2 to invade the central nervous system of rhesus monkeys","volume":"6","author":"Jiao","year":"2021","journal-title":"Signal. Transduct. Target. Ther."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1007\/s00415-020-09929-7","article-title":"Understanding the neurotropic characteristics of SARS-CoV-2: From neurological manifestations of COVID-19 to potential neurotropic mechanisms","volume":"267","author":"Zhou","year":"2020","journal-title":"J. Neurol."},{"key":"ref_99","doi-asserted-by":"crossref","unstructured":"Zingaropoli, M.A., Iannetta, M., Piermatteo, L., Pasculli, P., Latronico, T., Mazzuti, L., Campogiani, L., Duca, L., Ferraguti, G., and De Michele, M. (2022). Neuro-Axonal Damage and Alteration of Blood-Brain Barrier Integrity in COVID-19 Patients. Cells, 11.","DOI":"10.3390\/cells11162480"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1002\/jnr.20767","article-title":"Toll-like receptors in central nervous system glial inflammation and homeostasis","volume":"83","author":"Kielian","year":"2006","journal-title":"J. Neurosci. Res."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.it.2015.08.006","article-title":"Revisiting the Mechanisms of CNS Immune Privilege","volume":"36","author":"Louveau","year":"2015","journal-title":"Trends Immunol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/0042-6822(85)90246-6","article-title":"A Trojan Horse mechanism for the spread of visna virus in monocytes","volume":"147","author":"Peluso","year":"1985","journal-title":"Virology"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/322130a0","article-title":"Pathogenesis of lentivirus infections","volume":"322","author":"Haase","year":"1986","journal-title":"Nature"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"164","DOI":"10.2174\/1570162X12666140526122249","article-title":"\u03b2-Catenin\/TCF-4 signaling regulates susceptibility of macrophages and resistance of monocytes to HIV-1 productive infection","volume":"12","author":"Aljawai","year":"2014","journal-title":"Curr. HIV Res."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1086\/444461","article-title":"Detection of severe acute respiratory syndrome coronavirus in the brain: Potential role of the chemokine mig in pathogenesis","volume":"41","author":"Xu","year":"2005","journal-title":"Clin. Infect. Dis."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1038\/s41392-022-01112-w","article-title":"SARS-CoV-2 infection of monocytes: Balancing acts of antibodies and inflammasomes","volume":"7","author":"Brewer","year":"2022","journal-title":"Signal. Transduct. Target. Ther."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41582-022-00750-6","article-title":"Looking for lights in the fog of long-term neurological COVID","volume":"19","author":"Padovani","year":"2023","journal-title":"Nat. Rev. Neurol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1038\/s41591-022-02001-z","article-title":"Long-term neurologic outcomes of COVID-19","volume":"28","author":"Xu","year":"2022","journal-title":"Nat. Med."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/s41579-022-00846-2","article-title":"Long COVID: Major findings, mechanisms and recommendations","volume":"21","author":"Davis","year":"2023","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"n2342","DOI":"10.1136\/bmj.n2342","article-title":"Role of asymptomatic and pre-symptomatic infections in COVID-19 pandemic","volume":"375","author":"Gao","year":"2021","journal-title":"BMJ"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/S2213-2600(22)00126-6","article-title":"Health outcomes in people 2 years after surviving hospitalisation with COVID-19: A longitudinal cohort study","volume":"10","author":"Huang","year":"2022","journal-title":"Lancet Respir. Med."},{"key":"ref_112","unstructured":"The UNAIDS Global AIDS Update 2021 (2022, December 07). UNAIDS Report Shows That People Living with HIV Face a Double Jeopardy, HIV and COVID-19, While Key Populations and Children Continue to Be Left behind in Access to HIV Services. Available online: https:\/\/www.unaids.org\/en\/resources\/presscentre\/pressreleaseandstatementarchive\/2021\/july\/20210714_global-aids-update."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"864838","DOI":"10.3389\/fimmu.2022.864838","article-title":"Systematic Review and Meta-Analyses of THE Interaction between HIV Infection and COVID-19: Two Years\u2019 Evidence Summary","volume":"13","author":"Wang","year":"2022","journal-title":"Front. Immunol."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s11904-022-00618-w","article-title":"COVID-19 Outcomes and Risk Factors among People Living with HIV","volume":"19","author":"Spinelli","year":"2022","journal-title":"Curr. HIV\/AIDS Rep."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1007\/s10461-022-03578-9","article-title":"Risk Factors for COVID-19 Mortality among People Living with HIV: A Scoping Review","volume":"26","author":"Varshney","year":"2022","journal-title":"AIDS Behav."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0140-6736(08)61113-7","article-title":"Life expectancy of individuals on combination antiretroviral therapy in high-income countries: A collaborative analysis of 14 cohort studies","volume":"372","year":"2008","journal-title":"Lancet"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"209","DOI":"10.7326\/0003-4819-155-4-201108160-00358","article-title":"Life expectancy of persons receiving combination antiretroviral therapy in low-income countries: A cohort analysis from Uganda","volume":"155","author":"Mills","year":"2011","journal-title":"Ann. Intern. Med."},{"key":"ref_118","doi-asserted-by":"crossref","unstructured":"Samji, H., Cescon, A., Hogg, R.S., Modur, S.P., Althoff, K.N., Buchacz, K., Burchell, A.N., Cohen, M., Gebo, K.A., and Gill, M.J. (2013). Closing the gap: Increases in life expectancy among treated HIV-positive individuals in the United States and Canada. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0081355"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"e324","DOI":"10.1016\/S2352-3018(17)30086-3","article-title":"Improved life expectancy of people living with HIV: Who is left behind?","volume":"4","author":"Katz","year":"2017","journal-title":"Lancet HIV"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"e207954","DOI":"10.1001\/jamanetworkopen.2020.7954","article-title":"Comparison of Overall and Comorbidity-Free Life Expectancy Between Insured Adults with and Without HIV Infection, 2000\u20132016","volume":"3","author":"Marcus","year":"2020","journal-title":"JAMA Netw. Open."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.ijid.2022.05.055","article-title":"Risk Factors Associated with Severe\/Critical COVID-19 in People Living with HIV-1","volume":"122","author":"Bachelard","year":"2022","journal-title":"Int. J. Infect. Dis."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1089\/aid.2021.0005","article-title":"Pressing Questions and Challenges in the HIV-1 and SARS-CoV-2 Syndemic","volume":"37","author":"Montano","year":"2021","journal-title":"AIDS Res. Hum. Retrovir."},{"key":"ref_123","unstructured":"Centers for Disease Control and Prevention (2023, February 14). Risk for COVID-19 Infection, Hospitalization, and Death by Age Group, Available online: https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/COVID-data\/investigations-discovery\/hospitalization-death-by-age.html."},{"key":"ref_124","unstructured":"Centers for Disease Control and Prevention (2023, February 14). HIV and COVID-19 Basics, Available online: https:\/\/www.cdc.gov\/hiv\/basics\/COVID-19.html."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1097\/QAD.0000000000001245","article-title":"Effect of HIV-infection and cumulative viral load on age-related decline in grip strength","volume":"30","author":"Schrack","year":"2016","journal-title":"AIDS"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1007\/s13365-015-0366-7","article-title":"Elevated rates of mild cognitive impairment in HIV disease","volume":"21","author":"Sheppard","year":"2015","journal-title":"J. Neurovirol."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.immuni.2013.10.001","article-title":"Systemic effects of inflammation on health during chronic HIV infection","volume":"39","author":"Deeks","year":"2013","journal-title":"Immunity"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"e1222","DOI":"10.1093\/cid\/ciaa1864","article-title":"Human Immunodeficiency Virus (HIV) Care Models During the Coronavirus Disease 2019 (COVID-19) Era","volume":"73","author":"Guaraldi","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.3389\/fimmu.2020.01321","article-title":"Associations Between Plasma Immunomodulatory and Inflammatory Mediators with VACS Index Scores Among Older HIV-Infected Adults on Antiretroviral Therapy","volume":"11","author":"Premeaux","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/s41598-022-27328-y","article-title":"SARS-CoV-2 infection augments species- and age-specific predispositions in cotton rats","volume":"13","author":"Boukhvalova","year":"2023","journal-title":"Sci. Rep."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/s41577-020-0348-8","article-title":"Considering how biological sex impacts immune responses and COVID-19 outcomes","volume":"20","author":"Scully","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"20815","DOI":"10.1038\/s41598-021-00213-w","article-title":"Sex-differences in COVID-19 associated excess mortality is not exceptional for the COVID-19 pandemic","volume":"11","author":"Nielsen","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1016\/j.jaccas.2020.04.027","article-title":"Sex Differences in Mortality From COVID-19 Pandemic: Are Men Vulnerable and Women Protected?","volume":"2","author":"Sharma","year":"2020","journal-title":"JACC Case Rep."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/S0140-6736(20)31748-7","article-title":"Sex differential in COVID-19 mortality varies markedly by age","volume":"396","author":"Bhopal","year":"2020","journal-title":"Lancet"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3389\/fcvm.2020.00131","article-title":"COVID-19 Kills More Men Than Women: An Overview of Possible Reasons","volume":"7","author":"Capuano","year":"2020","journal-title":"Front. Cardiovasc. Med."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/s41586-020-2700-3","article-title":"Sex differences in immune responses that underlie COVID-19 disease outcomes","volume":"588","author":"Takahashi","year":"2020","journal-title":"Nature"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"16481","DOI":"10.1073\/pnas.2003603117","article-title":"Sex differences in neutrophil biology modulate response to type I interferons and immunometabolism","volume":"117","author":"Gupta","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1177\/1074248420967792","article-title":"Hypothesis: Sex-Related Differences in ACE2 Activity May Contribute to Higher Mortality in Men Versus Women With COVID-19","volume":"26","author":"Salah","year":"2021","journal-title":"J. Cardiovasc. Pharmacol. Ther."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1016\/j.mayocp.2020.07.024","article-title":"COVID-19 and Sex Differences: Mechanisms and Biomarkers","volume":"95","author":"Haitao","year":"2020","journal-title":"Mayo Clin. Proc."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.stem.2020.11.009","article-title":"Androgen Signaling Regulates SARS-CoV-2 Receptor Levels and Is Associated with Severe COVID-19 Symptoms in Men","volume":"27","author":"Samuel","year":"2020","journal-title":"Cell. Stem Cell."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"4068","DOI":"10.1038\/s41467-021-24342-y","article-title":"The antiandrogen enzalutamide downregulates TMPRSS2 and reduces cellular entry of SARS-CoV-2 in human lung cells","volume":"12","author":"Leach","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/andr.12821","article-title":"Low testosterone levels predict clinical adverse outcomes in SARS-CoV-2 pneumonia patients","volume":"9","author":"Rastrelli","year":"2021","journal-title":"Andrology"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"834851","DOI":"10.3389\/fimmu.2022.834851","article-title":"Association Between Sex Hormone Levels and Clinical Outcomes in Patients With COVID-19 Admitted to Hospital: An Observational, Retrospective, Cohort Study","volume":"13","author":"Beltrame","year":"2022","journal-title":"Front. Immunol."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"735638","DOI":"10.3389\/fendo.2021.735638","article-title":"Lowered Serum Testosterone Concentration Is Associated with Enhanced Inflammation and Worsened Lipid Profile in Men","volume":"12","author":"Grandys","year":"2021","journal-title":"Front. Endocrinol."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.ecl.2014.06.005","article-title":"Hypogonadism in the HIV-infected man","volume":"43","author":"Rochira","year":"2014","journal-title":"Endocrinol. Metab. Clin. North. Am."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"e270","DOI":"10.1016\/S2352-3018(17)30029-2","article-title":"Health-adjusted life expectancy in HIV-positive and HIV-negative men and women in British Columbia, Canada: A population-based observational cohort study","volume":"4","author":"Hogg","year":"2017","journal-title":"Lancet HIV"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1097\/COH.0000000000000079","article-title":"Multimorbidity and functional status assessment","volume":"9","author":"Guaraldi","year":"2014","journal-title":"Curr. Opin. HIV AIDS"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1097\/QAD.0000000000001096","article-title":"Sex differences in soluble markers vary before and after the initiation of antiretroviral therapy in chronically HIV-infected individuals","volume":"30","author":"Krebs","year":"2016","journal-title":"AIDS"},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"72","DOI":"10.32481\/djph.2021.12.016","article-title":"Characteristics and Outcomes of SARS-CoV-2 Infection Among Adults Living with HIV In Delaware: The Story of a Syndemic During the First 12 Months of the SARS-CoV-2 Pandemic","volume":"7","author":"Skrzynski","year":"2021","journal-title":"Dela J. Public Health"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1177\/0956462420973106","article-title":"Clinical characteristics and outcomes of people living with HIV hospitalized with COVID-19: A nationwide experience","volume":"32","author":"Ceballos","year":"2021","journal-title":"Int. J. STD AIDS"},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1080\/17571472.2014.11493422","article-title":"The prevalence of comorbidities among people living with HIV in Brent: A diverse London Borough","volume":"6","author":"Lorenc","year":"2014","journal-title":"London J. Prim. Care"},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.2147\/JMDH.S317884","article-title":"Comorbidities and Risk Factors for Severe Outcomes in COVID-19 Patients in Saudi Arabia: A Retrospective Cohort Study","volume":"14","author":"Shaikh","year":"2021","journal-title":"J. Multidiscip. Healthc."},{"key":"ref_153","doi-asserted-by":"crossref","unstructured":"MacNeill, J.J., Linnes, J.C., Hubach, R.D., and Rodriguez, N.M. (2022). From crisis to crisis: Impacts of the COVID-19 pandemic on people living with HIV and HIV\/AIDS service organizations in Indiana. BMC Health Serv. Res., 22.","DOI":"10.1186\/s12913-022-07998-0"},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ijid.2020.07.029","article-title":"Comorbidities and the risk of severe or fatal outcomes associated with coronavirus disease 2019: A systematic review and meta-analysis","volume":"99","author":"Zhou","year":"2020","journal-title":"Int. J. Infect. Dis."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s11904-023-00647-z","article-title":"Immunologic Interplay Between HIV\/AIDS and COVID-19: Adding Fuel to the Flames?","volume":"20","author":"Augello","year":"2023","journal-title":"Curr. HIV\/AIDS Rep."},{"key":"ref_156","doi-asserted-by":"crossref","unstructured":"Mazzitelli, M., Trunfio, M., Sasset, L., Leoni, D., Castelli, E., Lo Menzo, S., Gardin, S., Putaggio, C., Brundu, M., and Garzotto, P. (2022). Factors Associated with Severe COVID-19 and Post-Acute COVID-19 Syndrome in a Cohort of People Living with HIV on Antiretroviral Treatment and with Undetectable HIV RNA. Viruses, 14.","DOI":"10.3390\/v14030493"},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1093\/cid\/cit937","article-title":"Long-term immune responses to vaccination in HIV-infected patients: A systematic review and meta-analysis","volume":"58","author":"Kerneis","year":"2014","journal-title":"Clin. Infect. Dis."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.4049\/jimmunol.173.3.2184","article-title":"Central memory CD4+ T cell responses in chronic HIV infection are not restored by antiretroviral therapy","volume":"173","author":"Elrefaei","year":"2004","journal-title":"J. Immunol."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1093\/infdis\/jiz678","article-title":"Loss of Preexisting Immunological Memory Among Human Immunodeficiency Virus-Infected Women Despite Immune Reconstitution with Antiretroviral Therapy","volume":"222","author":"Thomas","year":"2020","journal-title":"J. Infect. Dis."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"536","DOI":"10.7326\/M20-3689","article-title":"Incidence and Severity of COVID-19 in HIV-Positive Persons Receiving Antiretroviral Therapy: A Cohort Study","volume":"173","author":"Polo","year":"2020","journal-title":"Ann. Intern. Med."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1097\/COH.0000000000000654","article-title":"The first 6 months of HIV-SARS-CoV-2 coinfection: Outcomes for 6947 individuals","volume":"16","author":"Johnston","year":"2021","journal-title":"Curr. Opin. HIV AIDS"},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"e069807","DOI":"10.1136\/bmj-2021-069807","article-title":"HIV and COVID-19 in South Africa","volume":"376","author":"Freer","year":"2022","journal-title":"BMJ"},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1037\/a0032694","article-title":"A pandemic of the poor: Social disadvantage and the U.S. HIV epidemic","volume":"68","author":"Pellowski","year":"2013","journal-title":"Am. Psychol."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.15585\/mmwr.mm6932a1","article-title":"Mental Health, Substance Use, and Suicidal Ideation During the COVID-19 Pandemic\u2014United States, June 24-30, 2020","volume":"69","author":"Czeisler","year":"2020","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1007\/s10461-020-02976-1","article-title":"Potential Influences of the COVID-19 Pandemic on Drug Use and HIV Care Among People Living with HIV and Substance Use Disorders: Experience from a Pilot mHealth Intervention","volume":"25","author":"Hochstatter","year":"2021","journal-title":"AIDS Behav."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"109297","DOI":"10.1016\/j.drugalcdep.2022.109297","article-title":"Risk factors for COVID-19 among persons with substance use disorder (PWSUD) with hospital visits\u2014United States, April 2020-December 2020","volume":"232","author":"Board","year":"2022","journal-title":"Drug. Alcohol. Depend."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1080\/08897077.2020.1784363","article-title":"COVID-19 and persons with substance use disorders: Inequities and mitigation strategies","volume":"41","author":"Melamed","year":"2020","journal-title":"Subst. Abus."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"e25583","DOI":"10.1002\/jia2.25583","article-title":"Challenges posed by COVID-19 to people who inject drugs and lessons from other outbreaks","volume":"23","author":"Vasylyeva","year":"2020","journal-title":"J. Int. AIDS Soc."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"e25551","DOI":"10.1002\/jia2.25551","article-title":"COVID-19 vulnerability among people who use drugs: Recommendations for global public health programmes and policies","volume":"23","author":"Holloway","year":"2020","journal-title":"J. Int. AIDS Soc."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41380-020-00880-7","article-title":"COVID-19 risk and outcomes in patients with substance use disorders: Analyses from electronic health records in the United States","volume":"26","author":"Wang","year":"2021","journal-title":"Mol. Psychiatry"},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1176\/appi.ps.202000534","article-title":"The Impact of Substance Use Disorder on COVID-19 Outcomes","volume":"72","author":"Baillargeon","year":"2021","journal-title":"Psychiatr. Serv."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1080\/10826084.2020.1791184","article-title":"Opioid Use Disorder and COVID-19: Biological Plausibility for Worsened Outcomes","volume":"55","author":"Schimmel","year":"2020","journal-title":"Subst. Use Misuse"},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"21m14332","DOI":"10.4088\/JCP.21m14332","article-title":"Impact of Cannabis Use, Substance Use Disorders, and Psychiatric Diagnoses on COVID-19 Outcomes: A Retrospective Cohort Study","volume":"83","author":"Ramakrishnan","year":"2022","journal-title":"J. Clin. Psychiatry"},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1056\/NEJMra2033007","article-title":"Substance Use among Men Who Have Sex with Men","volume":"385","author":"Compton","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1080\/02791072.2018.1447173","article-title":"Mental Health and Substance Use Disorder Comorbidity among Methamphetamine-Using Men Who have Sex with Men","volume":"50","author":"Fletcher","year":"2018","journal-title":"J. Psychoact. Drugs"},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"100097","DOI":"10.1016\/j.dadr.2022.100097","article-title":"Methamphetamine use and adoption of preventive behaviors early in the COVID-19 pandemic among men who have sex with men in Los Angeles, California","volume":"5","author":"Cohen","year":"2022","journal-title":"Drug. Alcohol. Depend. Rep."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1002\/jmv.26321","article-title":"HIV\/SARS-CoV-2 coinfection: A global perspective","volume":"93","author":"Kanwugu","year":"2021","journal-title":"J. Med. Virol."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/QAI.0000000000002822","article-title":"SARS-CoV-2 Infection Among People Living with HIV Compared With People Without HIV: Survey Results From the MACS-WIHS Combined Cohort Study","volume":"89","author":"Tong","year":"2022","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1080\/25787489.2021.1975608","article-title":"HIV and COVID-19: Review of clinical course and outcomes","volume":"22","author":"Barbera","year":"2021","journal-title":"HIV Res. Clin. Pract."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"6283","DOI":"10.1038\/s41598-021-85359-3","article-title":"Epidemiology and outcomes of COVID-19 in HIV-infected individuals: A systematic review and meta-analysis","volume":"11","author":"Ssentongo","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1002\/jmv.26352","article-title":"SARS-CoV-2 infection in persons living with HIV: A single center prospective cohort","volume":"93","author":"Maggiolo","year":"2021","journal-title":"J. Med. Virol."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"e21803","DOI":"10.1097\/MD.0000000000021803","article-title":"Analysis of type I IFN response and T cell activation in severe COVID-19\/HIV-1 coinfection: A case report","volume":"99","author":"Recchia","year":"2020","journal-title":"Medicine"},{"key":"ref_183","doi-asserted-by":"crossref","unstructured":"Singh, G.K., Arora, S., Ashta, K., and Singh, T. (2022). Clinical outcome of patients with HIV\/SARS-CoV-2 co-infection. Med. J. Armed Forces India, ahead of print.","DOI":"10.1016\/j.mjafi.2022.09.003"},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1002\/jmv.26533","article-title":"Clinical outcomes of patients with COVID-19 and HIV coinfection","volume":"93","author":"Nagarakanti","year":"2021","journal-title":"J. Med. Virol."},{"key":"ref_185","first-page":"47","article-title":"Novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) co-infection with HIV: Clinical case series analysis in North Central Nigeria","volume":"37","author":"Akyala","year":"2020","journal-title":"Pan Afr. Med. J."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"e314","DOI":"10.1016\/S2352-3018(20)30111-9","article-title":"COVID-19 in patients with HIV: Clinical case series","volume":"7","author":"Blanco","year":"2020","journal-title":"Lancet HIV"},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"827","DOI":"10.3389\/fimmu.2020.00827","article-title":"Reduction and Functional Exhaustion of T Cells in Patients with Coronavirus Disease 2019 (COVID-19)","volume":"11","author":"Diao","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s41182-020-00219-6","article-title":"What does the COVID-19 pandemic mean for HIV, tuberculosis, and malaria control?","volume":"48","author":"Amimo","year":"2020","journal-title":"Trop. Med. Health"},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1007\/s10461-020-02893-3","article-title":"COVID-19 Pandemic Disrupts HIV Continuum of Care and Prevention: Implications for Research and Practice Concerning Community-Based Organizations and Frontline Providers","volume":"24","author":"Pinto","year":"2020","journal-title":"AIDS Behav."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/jmv.26118","article-title":"Living with HIV in the time of COVID-19: A glimpse of hope","volume":"93","author":"Adadi","year":"2021","journal-title":"J. Med. Virol."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"e373","DOI":"10.1016\/S2352-3018(20)30143-0","article-title":"Lockdown fears for key populations","volume":"7","year":"2020","journal-title":"Lancet HIV"},{"key":"ref_192","first-page":"662","article-title":"A rapid assessment of the impact of the new coronavirus pneumonia epidemic on the health needs of HIV-infected patients","volume":"41","author":"Guo","year":"2020","journal-title":"Chin. J. Epidemiol."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"440","DOI":"10.5694\/mja2.50592","article-title":"Public health, health systems and palliation planning for COVID-19 on an exponential timeline","volume":"212","author":"MacIntyre","year":"2020","journal-title":"Med. J. Aust."},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s40463-020-00423-8","article-title":"Early recovery following new onset anosmia during the COVID-19 pandemic\u2014An observational cohort study","volume":"49","author":"Hopkins","year":"2020","journal-title":"J. Otolaryngol. Head. Neck Surg."},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1093\/cid\/ciaa330","article-title":"Self-reported Olfactory and Taste Disorders in Patients with Severe Acute Respiratory Coronavirus 2 Infection: A Cross-sectional Study","volume":"71","author":"Giacomelli","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"ref_196","unstructured":"The Joint United Nations Programme on HIV\/AIDS (UNAIDS) (2023, February 14). Global HIV & AIDS Statistics\u2014Fact Sheet. Available online: https:\/\/www.unaids.org\/en\/resources\/fact-sheet."},{"key":"ref_197","unstructured":"African Health Organization (2023, February 14). HIV and AIDS Fact Sheet. Available online: https:\/\/aho.org\/fact-sheets\/hiv-and-aids-fact-sheet\/."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"e13473","DOI":"10.1111\/apha.13473","article-title":"Neuroinfection may contribute to pathophysiology and clinical manifestations of COVID-19","volume":"229","author":"Steardo","year":"2020","journal-title":"Acta Physiol."},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3389\/fnagi.2018.00129","article-title":"Blood-Brain Barrier Disruption Induced Cognitive Impairment Is Associated with Increase of Inflammatory Cytokine","volume":"10","author":"Geng","year":"2018","journal-title":"Front. Aging Neurosci."},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.jinf.2020.03.037","article-title":"The pathogenesis and treatment of the \u2018Cytokine Storm\u2019 in COVID-19","volume":"80","author":"Ye","year":"2020","journal-title":"J. Infect."},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jpha.2020.03.001","article-title":"Molecular immune pathogenesis and diagnosis of COVID-19","volume":"10","author":"Li","year":"2020","journal-title":"J. Pharm. Anal."},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"3398","DOI":"10.1128\/JVI.78.7.3398-3406.2004","article-title":"Coronavirus neurovirulence correlates with the ability of the virus to induce proinflammatory cytokine signals from astrocytes and microglia","volume":"78","author":"Li","year":"2004","journal-title":"J. Virol."},{"key":"ref_204","first-page":"471","article-title":"Advances in the research of mechanism and related immunotherapy on the cytokine storm induced by coronavirus disease 2019","volume":"36","author":"Chen","year":"2020","journal-title":"Zhonghua Shao Shang Za Zhi"},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"104689","DOI":"10.1016\/j.psyneuen.2020.104689","article-title":"Peripheral immune dysregulation in the ART era of HIV-associated neurocognitive impairments: A systematic review","volume":"118","author":"Williams","year":"2020","journal-title":"Psychoneuroendocrinology"},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jneuroim.2013.09.005","article-title":"Relationship of plasma cytokines and clinical biomarkers to memory performance in HIV","volume":"265","author":"Correia","year":"2013","journal-title":"J. Neuroimmunol."},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"506872","DOI":"10.1155\/2015\/506872","article-title":"The relationship of CSF and plasma cytokine levels in HIV infected patients with neurocognitive impairment","volume":"2015","author":"Yuan","year":"2015","journal-title":"Biomed. Res. Int."},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/QAI.0000000000000458","article-title":"Abdominal obesity contributes to neurocognitive impairment in HIV-infected patients with increased inflammation and immune activation","volume":"68","author":"Sattler","year":"2015","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1590\/S0004-282X1992000200008","article-title":"Interleukin-6 and granulocyte macrophage-CSF in the cerebrospinal fluid from HIV infected subjects with involvement of the central nervous system","volume":"50","author":"Perrella","year":"1992","journal-title":"Arq. Neuropsiquiatr."},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s13365-017-0590-4","article-title":"Variability in C-reactive protein is associated with cognitive impairment in women living with and without HIV: A longitudinal study","volume":"24","author":"Rubin","year":"2018","journal-title":"J. Neurovirol."},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s13365-016-0505-9","article-title":"Cerebrospinal fluid biomarkers and HIV-associated neurocognitive disorders in HIV-infected individuals in Rakai, Uganda","volume":"23","author":"Abassi","year":"2017","journal-title":"J. Neurovirol."},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"3808","DOI":"10.1007\/s12035-018-1329-9","article-title":"Cerebrospinal Fluid Ceruloplasmin, Haptoglobin, and Vascular Endothelial Growth Factor Are Associated with Neurocognitive Impairment in Adults with HIV Infection","volume":"56","author":"Kallianpur","year":"2019","journal-title":"Mol. Neurobiol."},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"118097","DOI":"10.1016\/j.lfs.2020.118097","article-title":"The bio-mission of interleukin-6 in the pathogenesis of COVID-19: A brief look at potential therapeutic tactics","volume":"257","author":"Abbasifard","year":"2020","journal-title":"Life Sci."},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1126\/science.abb8925","article-title":"Cytokine release syndrome in severe COVID-19","volume":"368","author":"Moore","year":"2020","journal-title":"Science"},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1007\/s12291-021-00989-8","article-title":"Interleukin-6 Perpetrator of the COVID-19 Cytokine Storm","volume":"36","author":"Shekhawat","year":"2021","journal-title":"Indian J. Clin. Biochem."},{"key":"ref_216","first-page":"89","article-title":"Neurological Presentations in Patients with COVID-19 in Cytokine Storm","volume":"50","author":"Yuksel","year":"2021","journal-title":"Can. J. Neurol. Sci."},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1093\/eurheartj\/ehaa1103","article-title":"C-reactive protein and clinical outcomes in patients with COVID-19","volume":"42","author":"Smilowitz","year":"2021","journal-title":"Eur. Heart J."},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1021\/acschemneuro.0c00294","article-title":"Vascular Endothelial Growth Factor (VEGF) as a Vital Target for Brain Inflammation during the COVID-19 Outbreak","volume":"11","author":"Yin","year":"2020","journal-title":"ACS Chem. Neurosci."},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"949787","DOI":"10.3389\/fimmu.2022.949787","article-title":"Saliva antibody-fingerprint of reactivated latent viruses after mild\/asymptomatic COVID-19 is unique in patients with myalgic-encephalomyelitis\/chronic fatigue syndrome","volume":"13","author":"Apostolou","year":"2022","journal-title":"Front. Immunol."},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"4888","DOI":"10.1038\/s41467-022-32376-z","article-title":"SARS-CoV-2 mRNA vaccination exposes latent HIV to Nef-specific CD8(+) T-cells","volume":"13","author":"Stevenson","year":"2022","journal-title":"Nat. Commun."},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/s41577-020-0343-0","article-title":"COVID-19: The vasculature unleashed","volume":"20","author":"Teuwen","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1056\/NEJMc2033369","article-title":"Microvascular Injury in the Brains of Patients with COVID-19","volume":"384","author":"Lee","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_223","doi-asserted-by":"crossref","first-page":"698169","DOI":"10.3389\/fmicb.2021.698169","article-title":"Long COVID or Post-acute Sequelae of COVID-19 (PASC): An Overview of Biological Factors That May Contribute to Persistent Symptoms","volume":"12","author":"Proal","year":"2021","journal-title":"Front. Microbiol."},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"F7","DOI":"10.1097\/QAD.0000000000003338","article-title":"Postacute sequelae and adaptive immune responses in people with HIV recovering from SARS-CoV-2 infection","volume":"36","author":"Peluso","year":"2022","journal-title":"AIDS"},{"key":"ref_225","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1002\/iid3.467","article-title":"Long-coronavirus disease among people living with HIV in western India: An observational study","volume":"9","author":"Pujari","year":"2021","journal-title":"Immun. Inflamm. Dis."},{"key":"ref_226","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1007\/s11606-021-07379-z","article-title":"Health Status, Persistent Symptoms, and Effort Intolerance One Year After Acute COVID-19 Infection","volume":"37","author":"Kingery","year":"2022","journal-title":"J. Gen. Intern. Med."},{"key":"ref_227","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/s41590-021-01113-x","article-title":"Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection","volume":"23","author":"Phetsouphanh","year":"2022","journal-title":"Nat. Immunol."},{"key":"ref_228","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1093\/infdis\/jiv123","article-title":"Factors Associated With Plasma IL-6 Levels During HIV Infection","volume":"212","author":"Borges","year":"2015","journal-title":"J. Infect. Dis."},{"key":"ref_229","doi-asserted-by":"crossref","unstructured":"Serrano-Villar, S., Sainz, T., Lee, S.A., Hunt, P.W., Sinclair, E., Shacklett, B.L., Ferre, A.L., Hayes, T.L., Somsouk, M., and Hsue, P.Y. (2014). HIV-infected individuals with low CD4\/CD8 ratio despite effective antiretroviral therapy exhibit altered T cell subsets, heightened CD8+ T cell activation, and increased risk of non-AIDS morbidity and mortality. PLoS Pathog., 10.","DOI":"10.1371\/journal.ppat.1004078"},{"key":"ref_230","doi-asserted-by":"crossref","unstructured":"Zicari, S., Sessa, L., Cotugno, N., Ruggiero, A., Morrocchi, E., Concato, C., Rocca, S., Zangari, P., Manno, E.C., and Palma, P. (2019). Immune Activation, Inflammation, and Non-AIDS Co-Morbidities in HIV-Infected Patients under Long-Term ART. Viruses, 11.","DOI":"10.3390\/v11030200"},{"key":"ref_231","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1186\/s12933-021-01359-7","article-title":"Persistent clotting protein pathology in Long COVID\/Post-Acute Sequelae of COVID-19 (PASC) is accompanied by increased levels of antiplasmin","volume":"20","author":"Pretorius","year":"2021","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_232","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.cell.2022.01.014","article-title":"Multiple early factors anticipate post-acute COVID-19 sequelae","volume":"185","author":"Su","year":"2022","journal-title":"Cell"},{"key":"ref_233","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1093\/infdis\/jix039","article-title":"Human Immunodeficiency Virus Persistence and T-Cell Activation in Blood, Rectal, and Lymph Node Tissue in Human Immunodeficiency Virus-Infected Individuals Receiving Suppressive Antiretroviral Therapy","volume":"215","author":"Khoury","year":"2017","journal-title":"J. Infect. Dis."},{"key":"ref_234","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S1568-9972(02)00086-1","article-title":"HIV and autoimmunity","volume":"1","author":"Shoenfeld","year":"2002","journal-title":"Autoimmun. Rev."},{"key":"ref_235","doi-asserted-by":"crossref","first-page":"100603","DOI":"10.1016\/j.eclinm.2020.100603","article-title":"The potential impact of the COVID-19 pandemic on the tuberculosis epidemic a modelling analysis","volume":"28","author":"Cilloni","year":"2020","journal-title":"EClinicalMedicine"},{"key":"ref_236","doi-asserted-by":"crossref","unstructured":"Kelley, N., Jeltema, D., Duan, Y., and He, Y. (2019). The NLRP3 Inflammasome: An Overview of Mechanisms of Activation and Regulation. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20133328"},{"key":"ref_237","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.smim.2009.05.002","article-title":"The NLRP3 inflammasome: A sensor of immune danger signals","volume":"21","author":"Cassel","year":"2009","journal-title":"Semin. Immunol."},{"key":"ref_238","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1038\/s41423-021-00740-6","article-title":"NLRP3 inflammasome activation and cell death","volume":"18","author":"Huang","year":"2021","journal-title":"Cell. Mol. Immunol."},{"key":"ref_239","first-page":"138","article-title":"NLRP3 inflammasome activation and SARS-CoV-2-mediated hyperinflammation, cytokine storm and neurological syndromes","volume":"14","author":"Dutta","year":"2022","journal-title":"Int. J. Physiol. Pathophysiol. Pharmacol."},{"key":"ref_240","doi-asserted-by":"crossref","first-page":"102295","DOI":"10.1016\/j.isci.2021.102295","article-title":"SARS-CoV-2, SARS-CoV-1, and HIV-1 derived ssRNA sequences activate the NLRP3 inflammasome in human macrophages through a non-classical pathway","volume":"24","author":"Campbell","year":"2021","journal-title":"iScience"},{"key":"ref_241","doi-asserted-by":"crossref","first-page":"577728","DOI":"10.1016\/j.jneuroim.2021.577728","article-title":"The microglial NLRP3 inflammasome is involved in human SARS-CoV-2 cerebral pathogenicity: A report of three post-mortem cases","volume":"361","author":"Cama","year":"2021","journal-title":"J. Neuroimmunol."},{"key":"ref_242","doi-asserted-by":"crossref","first-page":"4664","DOI":"10.1038\/s41467-021-25015-6","article-title":"SARS-CoV-2 N protein promotes NLRP3 inflammasome activation to induce hyperinflammation","volume":"12","author":"Pan","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_243","doi-asserted-by":"crossref","first-page":"24432","DOI":"10.1038\/s41598-021-04133-7","article-title":"Modulation of the NLRP3 inflammasome by SARS-CoV-2 Envelope protein","volume":"11","author":"Yalcinkaya","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_244","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.ajpath.2015.10.002","article-title":"HIV Promotes NLRP3 Inflammasome Complex Activation in Murine HIV-Associated Nephropathy","volume":"186","author":"Haque","year":"2016","journal-title":"Am. J. Pathol."},{"key":"ref_245","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/s41423-019-0260-y","article-title":"NLRP3-dependent pyroptosis is required for HIV-1 gp120-induced neuropathology","volume":"17","author":"He","year":"2020","journal-title":"Cell. Mol. Immunol."},{"key":"ref_246","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1523\/JNEUROSCI.3045-16.2017","article-title":"HIV-1 Tat Primes and Activates Microglial NLRP3 Inflammasome-Mediated Neuroinflammation","volume":"37","author":"Chivero","year":"2017","journal-title":"J. Neurosci."},{"key":"ref_247","doi-asserted-by":"crossref","unstructured":"Gumbs, S.B.H., Berdenis van Berlekom, A., Kubler, R., Schipper, P.J., Gharu, L., Boks, M.P., Ormel, P.R., Wensing, A.M.J., de Witte, L.D., and Nijhuis, M. (2022). Characterization of HIV-1 Infection in Microglia-Containing Human Cerebral Organoids. Viruses, 14.","DOI":"10.3390\/v14040829"},{"key":"ref_248","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.trsl.2022.07.008","article-title":"Inflammasomes as mediators of inflammation in HIV-1 infection","volume":"252","author":"Min","year":"2023","journal-title":"Transl. Res."},{"key":"ref_249","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/joim.12570","article-title":"Alarmins and central nervous system inflammation in HIV-associated neurological disorders","volume":"281","author":"Gougeon","year":"2017","journal-title":"J. Intern. Med."},{"key":"ref_250","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s11481-016-9708-3","article-title":"HIV-1 Viral Protein R Activates NLRP3 Inflammasome in Microglia: Implications for HIV-1 Associated Neuroinflammation","volume":"12","author":"Mamik","year":"2017","journal-title":"J. Neuroimmune Pharmacol."},{"key":"ref_251","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.cytogfr.2020.06.001","article-title":"SARS-CoV-2 infection: The role of cytokines in COVID-19 disease","volume":"54","author":"Ruiz","year":"2020","journal-title":"Cytokine Growth Factor. Rev."},{"key":"ref_252","doi-asserted-by":"crossref","first-page":"589095","DOI":"10.3389\/fimmu.2021.589095","article-title":"Cytokine Storm: The Primary Determinant for the Pathophysiological Evolution of COVID-19 Deterioration","volume":"12","author":"Chen","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_253","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cytogfr.2021.02.002","article-title":"SARS-CoV-2 mediated neuroinflammation and the impact of COVID-19 in neurological disorders","volume":"58","author":"Amruta","year":"2021","journal-title":"Cytokine Growth Factor. Rev."},{"key":"ref_254","doi-asserted-by":"crossref","first-page":"105131","DOI":"10.1016\/j.nbd.2020.105131","article-title":"The SARS-CoV-2 spike protein alters barrier function in 2D static and 3D microfluidic in-vitro models of the human blood-brain barrier","volume":"146","author":"Buzhdygan","year":"2020","journal-title":"Neurobiol. Dis."},{"key":"ref_255","doi-asserted-by":"crossref","first-page":"756","DOI":"10.14336\/AD.2020.0601","article-title":"Age-induced NLRP3 Inflammasome Over-activation Increases Lethality of SARS-CoV-2 Pneumonia in Elderly Patients","volume":"11","author":"Lara","year":"2020","journal-title":"Aging Dis."},{"key":"ref_256","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.cell.2020.09.018","article-title":"Molecular Architecture of the SARS-CoV-2 Virus","volume":"183","author":"Yao","year":"2020","journal-title":"Cell"},{"key":"ref_257","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/s41579-021-00630-8","article-title":"Structural biology of SARS-CoV-2 and implications for therapeutic development","volume":"19","author":"Yang","year":"2021","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_258","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.virol.2022.01.003","article-title":"SARS-CoV-2 viroporin encoded by ORF3a triggers the NLRP3 inflammatory pathway","volume":"568","author":"Xu","year":"2022","journal-title":"Virology"},{"key":"ref_259","doi-asserted-by":"crossref","first-page":"e14150","DOI":"10.15252\/emmm.202114150","article-title":"Long-lived macrophage reprogramming drives spike protein-mediated inflammasome activation in COVID-19","volume":"13","author":"Theobald","year":"2021","journal-title":"EMBO Mol. Med."},{"key":"ref_260","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1007\/s10753-021-01464-5","article-title":"Induction of Exaggerated Cytokine Production in Human Peripheral Blood Mononuclear Cells by a Recombinant SARS-CoV-2 Spike Glycoprotein S1 and Its Inhibition by Dexamethasone","volume":"44","author":"Olajide","year":"2021","journal-title":"Inflammation"},{"key":"ref_261","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.virusres.2009.01.005","article-title":"SARS coronavirus spike protein-induced innate immune response occurs via activation of the NF-kappaB pathway in human monocyte macrophages in vitro","volume":"142","author":"Dosch","year":"2009","journal-title":"Virus Res."},{"key":"ref_262","doi-asserted-by":"crossref","first-page":"728896","DOI":"10.3389\/fimmu.2021.728896","article-title":"SARS-CoV-2 Coronavirus Spike Protein-Induced Apoptosis, Inflammatory, and Oxidative Stress Responses in THP-1-Like-Macrophages: Potential Role of Angiotensin-Converting Enzyme Inhibitor (Perindopril)","volume":"12","author":"Barhoumi","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_263","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.bbi.2021.12.007","article-title":"SARS-CoV-2 spike S1 subunit induces neuroinflammatory, microglial and behavioral sickness responses: Evidence of PAMP-like properties","volume":"100","author":"Frank","year":"2022","journal-title":"Brain Behav. Immun."},{"key":"ref_264","doi-asserted-by":"crossref","first-page":"5496","DOI":"10.1038\/s41598-022-09410-7","article-title":"SARS-CoV-2 spike protein induces cognitive deficit and anxiety-like behavior in mouse via non-cell autonomous hippocampal neuronal death","volume":"12","author":"Oh","year":"2022","journal-title":"Sci. Rep."},{"key":"ref_265","doi-asserted-by":"crossref","first-page":"e108249","DOI":"10.15252\/embj.2021108249","article-title":"SARS-CoV-2 nucleocapsid suppresses host pyroptosis by blocking Gasdermin D cleavage","volume":"40","author":"Ma","year":"2021","journal-title":"EMBO J."},{"key":"ref_266","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/s41392-021-00742-w","article-title":"A dual-role of SARS-CoV-2 nucleocapsid protein in regulating innate immune response","volume":"6","author":"Zhao","year":"2021","journal-title":"Signal. Transduct. Target. Ther."},{"key":"ref_267","doi-asserted-by":"crossref","first-page":"104299","DOI":"10.1016\/j.ebiom.2022.104299","article-title":"Interleukin-1 and the NLRP3 inflammasome in COVID-19: Pathogenetic and therapeutic implications","volume":"85","author":"Potere","year":"2022","journal-title":"EBioMedicine"},{"key":"ref_268","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/s41586-021-03553-9","article-title":"High-dimensional characterization of post-acute sequelae of COVID-19","volume":"594","author":"Xie","year":"2021","journal-title":"Nature"},{"key":"ref_269","unstructured":"World Health Organization (2022). COVID-19 Pandemic Triggers 25% Increase in Prevalence of Anxiety and Depression Worldwide, WHO."},{"key":"ref_270","doi-asserted-by":"crossref","first-page":"581","DOI":"10.7326\/L20-1399","article-title":"Incidence and Severity of COVID-19 in HIV-Positive Persons Receiving Antiretroviral Therapy","volume":"174","author":"Polo","year":"2021","journal-title":"Ann. Intern. Med."},{"key":"ref_271","doi-asserted-by":"crossref","first-page":"580","DOI":"10.7326\/L20-1398","article-title":"Incidence and Severity of COVID-19 in HIV-Positive Persons Receiving Antiretroviral Therapy","volume":"174","author":"Titanji","year":"2021","journal-title":"Ann. Intern. Med."},{"key":"ref_272","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.1007\/s10461-020-02935-w","article-title":"\u201cEverything is a Mess\u201d: How COVID-19 is Impacting Engagement with HIV Testing Services in Rural Southwestern Uganda","volume":"24","author":"Ponticiello","year":"2020","journal-title":"AIDS Behav."},{"key":"ref_273","doi-asserted-by":"crossref","first-page":"020342","DOI":"10.7189\/jogh.10.020342","article-title":"Concerns of HIV-positive migrant workers in COVID-19 pandemic: A call for action","volume":"10","author":"Ahmed","year":"2020","journal-title":"J. Glob. Health"},{"key":"ref_274","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1089\/apc.2020.0092","article-title":"COVID-19, HIV, and Migrant Workers: The Double Burden of the Two Viruses","volume":"34","author":"Lodge","year":"2020","journal-title":"AIDS Patient Care STDS"},{"key":"ref_275","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.ijid.2020.05.013","article-title":"HIV care in times of the COVID-19 crisis\u2014Where are we now in Central and Eastern Europe?","volume":"96","author":"Kowalska","year":"2020","journal-title":"Int. J. Infect. Dis."},{"key":"ref_276","doi-asserted-by":"crossref","first-page":"e629","DOI":"10.1016\/S2352-3018(20)30211-3","article-title":"Potential effects of disruption to HIV programmes in sub-Saharan Africa caused by COVID-19: Results from multiple mathematical models","volume":"7","author":"Jewell","year":"2020","journal-title":"Lancet HIV"},{"key":"ref_277","doi-asserted-by":"crossref","first-page":"883453","DOI":"10.3389\/fpubh.2022.883453","article-title":"COVID-19 Vaccination Willingness Among People Living with HIV in Wuhan, China","volume":"10","author":"Wu","year":"2022","journal-title":"Front. Public. Health"},{"key":"ref_278","doi-asserted-by":"crossref","unstructured":"Hensley, K.S., Jongkees, M.J., Geers, D., GeurtsvanKessel, C.H., Mueller, Y.M., Dalm, V., Papageorgiou, G., Steggink, H., Gorska, A., and Bogers, S. (2022). Immunogenicity and reactogenicity of SARS-CoV-2 vaccines in people living with HIV in the Netherlands: A nationwide prospective cohort study. PLoS Med., 19.","DOI":"10.1101\/2022.03.31.22273221"}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/15\/5\/1117\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T19:29:40Z","timestamp":1760124580000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/15\/5\/1117"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,5]]},"references-count":278,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2023,5]]}},"alternative-id":["v15051117"],"URL":"https:\/\/doi.org\/10.3390\/v15051117","relation":{},"ISSN":["1999-4915"],"issn-type":[{"value":"1999-4915","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,5]]}}}